The Ministry makes Official Information Act (OIA) responses available where the information is considered to be of public interest, and where there is no risk to the privacy of individuals. The names and contact details of requestors are removed before publication.
To find out more about making an OIA request, visit OIA requests, where you can make a request via the online tool. Alternatively you can email the OIA Services team.
Documents are usually available in Adobe PDF format only.
| Publication date | Response date | Details of the request | Download |
|---|---|---|---|
| 14 September 2021 | 20 April 2021 | Information on pharmacies in New Zealand (as at April 2021) | H202104488 Response (pdf, 1.6 MB) |
| 06 September 2021 | 03 September 2021 | Briefings relating to strengthening food environments | H202108521 Response (pdf, 4.3 MB) |
| 24 August 2021 | 16 August 2021 | Adverse events following immunisation (AEFI) reported with COVID-19 vaccines |
H202109034 (pdf, 120 KB) H202109086 (pdf, 133 KB) |
| 24 August 2021 | 06 August 2021 | COVID-19 vaccine purchase agreement with Pfizer | H202109731 (pdf, 193 KB) |
| 24 August 2021 | 05 August 2021 | Information regarding the Pfizer vaccine (Comirnaty) |
H202105715 (pdf, 158 KB) H202109031 (pdf, 171 KB) H202109490 (pdf, 288 KB) |
| 24 August 2021 | 16 July 2021 | Clinical considerations for COVID-19 vaccine use |
H202108423 (pdf, 170 KB) H202108431 (pdf, 178 KB) |
| 29 July 2021 | 28 July 2021 | Information on CT value in Covid-19 RT-PCR testing | H202109044 Response (pdf, 2 MB) |
| 29 July 2021 | 24 June 2021 | Data on psychiatric medicine prescriptions | H202106582 Response (pdf, 1.1 MB) |
| 05 July 2021 | 27 August 2020 | Information relating to MIQ costs |
H20200535 Response (pdf, 797 KB) H20205363 Response (pdf, 893 KB) H20205365 Response (pdf, 811 KB) H20206135 Response (pdf, 806 KB) H20208980 Response (pdf, 734 KB) H20205357 Response (pdf, 757 KB) |
| 29 June 2021 | 28 June 2021 | Data on COVID-19 vaccinations broken down by priority groups | H202107160 Response (pdf, 815 KB) |
| 29 June 2021 | 24 June 2021 | Information on adverse events following immunisation - COMIRNATY vaccine | H202106405 Response (pdf, 129 KB) |
| 29 June 2021 | 18 May 2021 | Information on digital vaccine certification | H202105321 Response (pdf, 3.2 MB) |
| 21 June 2021 | 09 November 2020 | Information on COVID-19 PCR testing | H202007924 Response (pdf, 175 KB) |
| 21 June 2021 | 09 November 2020 | Information on COVID-19 PCR testing | H202007924 Response (pdf, 175 KB) |
| 24 May 2021 | 17 May 2021 | Information on the COVID-19 Immunisation Register | H202104358 Response (pdf, 10.4 MB) |
| 24 May 2021 | 10 May 2021 | Mental health and wellbeing in MIQ facilities | H202100129 Response (pdf, 813 KB) |
| 18 May 2021 | 18 May 2021 | Information on cannabidiol products supplied under s29 of the Medicines Act 1981 | H202103709 Response (pdf, 1.3 MB) |
| 10 May 2021 | 10 May 2021 | Documents relating to improving public health measures | H202008242 Response (pdf, 2.5 MB) |
| 10 May 2021 | 10 May 2021 | Information about about the Pfizer (COMIRNATY) vaccine. | H202104662 Response (pdf, 181 KB) |
| 10 May 2021 | 10 May 2021 | Information on COVID-19 | H202104788 Response (pdf, 212 KB) |
| 03 May 2021 | COVID-19 cases in MIQ facilities based on country of origin | H202104105 (pdf, 2.7 MB) | |
| 30 April 2021 | 17 March 2021 | Data on antidepressant prescriptions 2017-2021 | H202101435 (pdf, 1.2 MB) |
| 15 April 2021 | 25 March 2021 | Briefings on COVID-19 vaccine rollout | H202100194 H202100195 (pdf, 3.5 MB) |
| 13 April 2021 | 08 April 2021 | Positive COVID-19 (including confirmed and probable cases) in Managed Isolation and Quarantine Facilities (MIQF). | H202102941 (pdf, 2.2 MB) |
| 13 April 2021 | 25 March 2021 | COVID-19 testing protocols | H202102835 (pdf, 169 KB) |
| 13 April 2021 | 19 February 2021 | National Asset Management Programme reports on mental health and intellectual disability units | H202009166 (pdf, 11 MB) |
| 09 April 2021 | 07 April 2021 | COVID-19 mRNA-based vaccine | H202102876 (pdf, 183 KB) |
| 31 March 2021 | 03 February 2021 | Shaken Baby or Paediatric Abusive Head Trauma | H202009289 (pdf, 2.8 MB) |
| 31 March 2021 | 03 February 2021 | Sudden Unexpected Death in Infancy (SUDI) questions | H202009294 (pdf, 341 KB) |
| 26 March 2021 | 02 March 2021 | COVID Tracer App information and cost | H202009295 2 Feb 2021 (pdf, 3.4 MB) |
| 26 March 2021 | 02 February 2021 | COVID PCR test and test kit information | H202100145 2 Feb 2021 (pdf, 202 KB) |
| 26 March 2021 | 02 February 2021 | COVID various testing and vaccine questions | H202009440 2 Feb 2021 (pdf, 174 KB) |
| 26 March 2021 | 02 February 2021 | COVID Virus isolation | H202100116 2 Feb 2021 (pdf, 372 KB) |
| 26 March 2021 | 01 February 2021 | COVID immunisation certificate and quarantine questions | H202100035 1 Feb 2021 (pdf, 236 KB) |
| 26 March 2021 | 01 February 2021 | COVID use of hydroxychloroquine | H202100277 1 Feb 2021 (pdf, 136 KB) |
| 26 March 2021 | 01 February 2021 | COVID vaccine safety | H202100314 1 Feb 2021 (pdf, 170 KB) |
| 26 March 2021 | 01 February 2021 | Data on adverse events involving medical devices | H202108538 1 Feb 2021 (pdf, 945 KB) |
| 26 March 2021 | 01 February 2021 | Flu vaccinations and positive COVID tests | H202100064 1 Feb 2021 (pdf, 2.1 MB) |
| 26 March 2021 | 01 February 2021 | Personal protective equipment from specific suppliers | H202009422 1 Feb 2021 (pdf, 119 KB) |
| 23 March 2021 | 23 March 2021 | COVID PCR test swab manufaturers | H202102134 23 March 2021 (pdf, 137 KB) |
| 23 March 2021 | 23 March 2021 | Use of puberty blockers | H202103211 23 March 2021 (pdf, 214 KB) |
| 18 March 2021 | 12 March 2021 | COVID-19 Vaccine information for recipients | H202101370 (pdf, 1.5 MB) |
| 17 March 2021 | 11 March 2021 | Arrivals from Australia and COVID-19 data | H202101942 11 March 2021 (pdf, 260 KB) |
| 16 March 2021 | 29 January 2021 | Reviews of Canterbury DHB capacity | H202009434 (pdf, 3.3 MB) |
| 16 March 2021 | 28 January 2021 | Aged care facilities and respite under 65s | H202100333 (pdf, 2.1 MB) |
| 16 March 2021 | 28 January 2021 | COVID-19 various questions about virus and vaccine | H202009196 (pdf, 2.4 MB) |
| 16 March 2021 | 28 January 2021 | Medicinal cannabis and CBD products | H202009007 (pdf, 124 KB) |
| 16 March 2021 | 28 January 2021 | Patient transport and care following surgery | H202009231 (pdf, 2.4 MB) |
| 16 March 2021 | 27 January 2021 | COVID testing | H202100094 (pdf, 174 KB) |
| 16 March 2021 | 26 January 2021 | COVID-19 Cycle Threshold value for PCR testing | H202100070 (pdf, 188 KB) |
| 16 March 2021 | 26 January 2021 | Early medical abortions data | H202009427 (pdf, 353 KB) |
| 16 March 2021 | 21 January 2021 | COVID-19 PCR testing kits | H202009192 (pdf, 157 KB) |
| 16 March 2021 | 20 January 2021 | Recruitment of research advisors / analysts | H202009298 (pdf, 857 KB) |
| 16 March 2021 | 19 January 2021 | COVID-19 vaccine effect | H202100059 (pdf, 408 KB) |
| 16 March 2021 | 19 January 2021 | Elective surgery data | H202009181 (pdf, 4.1 MB) |
| 16 March 2021 | 02 December 2020 | Face mask analysis | H202008389 (pdf, 220 KB) |
| 10 March 2021 | 28 January 2021 | COVID-19 test results; various questions | H202009165 (pdf, 1.3 MB) |
| 10 March 2021 | 28 January 2021 | COVID-19 various questions about virus and vaccine | H202009196 (pdf, 2.4 MB) |
| 10 March 2021 | 28 January 2021 | Sepsis data | H20210030 (pdf, 2.8 MB) |
| 10 March 2021 | 27 January 2021 | COVID-19 vaccine information and adverse reaction questions | H202008399 (pdf, 134 KB) |
| 10 March 2021 | 27 January 2021 | MIQ costs May 2020 | H202008980 (pdf, 174 KB) |
| 10 March 2021 | 21 January 2021 | All information on Bluetooth technology use in COVID contact tracing | H202008240 (pdf, 9.4 MB) |
| 10 March 2021 | 21 January 2021 | COVID-19 Alert Level 4 decision | H202008777 (pdf, 297 KB) |
| 10 March 2021 | 20 January 2021 | COVID-19 contact tracing information | H202008171 (pdf, 2.6 MB) |
| 10 March 2021 | 20 January 2021 | Health Improvement Practitioners and Health Coaches | H202008634 (pdf, 215 KB) |
| 10 March 2021 | 18 January 2021 | Abortion statistics | H202008401 (pdf, 187 KB) |
| 10 March 2021 | 15 January 2021 | Elective Services Patient Flow Indicators (ESPIs) data by DHB | H202009432 (pdf, 423 KB) |
| 10 March 2021 | 13 January 2021 | GP enrolment data Auckland region | H202008532 (pdf, 126 KB) |
| 10 March 2021 | 11 January 2021 | COVID-19 PCR testing cycles | H202008534 (pdf, 158 KB) |
| 10 March 2021 | 21 December 2020 | Sudden Unexpected Death in Infancy (SUDI) | H202007923 21 Dec 2020 (pdf, 13.9 MB) |
| 08 March 2021 | 18 February 2021 | Medicinal Cannabis product applications as at February 2021 | H202100053 18 Feb 2021 (pdf, 262 KB) |
| 08 March 2021 | 17 February 2021 | Medicinal cannabis prescription data | H202100310 17 Feb 2021 (pdf, 110 KB) |
| 08 March 2021 | 14 December 2020 | Medicinal cannabis prescription various data and information | H2021007921 14 Dec 2020 (pdf, 178 KB) |
| 08 March 2021 | 10 December 2020 | Medicinal cannabis product applications as at November 2020 | H202008432 10 Dec 2020 (pdf, 194 KB) |
| 08 March 2021 | 07 October 2020 | Medicinal cannabis cultivation licence numbers | H202007069 7 Oct 2020 (pdf, 115 KB) |
| 08 March 2021 | 06 October 2020 | Medicinal cannabis product assessment applications | H202007018 6 Oct 2020 (pdf, 192 KB) |
| 08 March 2021 | 22 September 2020 | Medicinal cannabis applications for assessment | H202006656 22 Sept 2020 (pdf, 118 KB) |
| 08 March 2021 | 14 September 2020 | Prescriptions for cannabis products and applications for licences | H202006051 14 Sept 2020 (pdf, 216 KB) |
| 08 March 2021 | 10 September 2020 | Cannabidiol product distribution numbers | H202006140 10 Sept 2020 (pdf, 137 KB) |
| 08 March 2021 | 09 September 2020 | Medicinal cannabis approvals | H202006136 9 Sept 2020 (pdf, 518 KB) |
| 08 March 2021 | 04 September 2020 | Prescription cannabis products | H202006002 4 Sept 2020 (pdf, 742 KB) |
| 08 March 2021 | 25 August 2020 | Medicinal cannabis licences as at August 2020 | H202005977 25 Aug 2020 (pdf, 358 KB) |
| 08 March 2021 | 29 July 2020 | Cannabidiol (CBD) products | H202005124 29 July 2020 (pdf, 580 KB) |
| 05 March 2021 | 15 February 2021 | COVID-19 use of Ivermectin | H202100482 15 Feb 2021 (pdf, 181 KB) |
| 01 March 2021 | 01 March 2021 | COVID-19 PCR testing qualitative or quantitative | H202102074 (pdf, 252 KB) |
| 24 February 2021 | 24 February 2021 | COVID-19 vaccines individual rights and safety | H202100534 24 Feb 2021 (pdf, 236 KB) |
| 24 February 2021 | 23 February 2021 | COVID-19 various questions on testing and vaccine including transportation and storage | H202100399 23 February 2021 (pdf, 251 KB) |
| 17 February 2021 | 17 February 2021 | COVID-19 mRNA Spike protein antibody research | H202101220 (pdf, 271 KB) |
| 01 February 2021 | 10 August 2020 | Documents related to the National Asset Management Programme report | H202004703 10 Aug 2020 (pdf, 7.6 MB) |
| 20 January 2021 | 19 January 2021 | Vaccine investment and liability | H202008610 19 Jan 2021 (pdf, 2.4 MB) |